Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $452.9 million.

  • Collegium Pharmaceutical's Total Current Liabilities fell 141.42% to $452.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $452.9 million, marking a year-over-year decrease of 141.42%. This contributed to the annual value of $509.5 million for FY2024, which is 1126.74% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Total Current Liabilities stood at $452.9 million for Q3 2025, which was down 141.42% from $464.6 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Total Current Liabilities' 5-year high stood at $509.5 million during Q4 2024, with a 5-year trough of $226.8 million in Q2 2021.
  • In the last 5 years, Collegium Pharmaceutical's Total Current Liabilities had a median value of $435.1 million in 2023 and averaged $405.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 1002.26% in 2021, then skyrocketed by 8298.74% in 2022.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Total Current Liabilities stood at $279.6 million in 2021, then skyrocketed by 55.14% to $433.7 million in 2022, then rose by 5.58% to $457.9 million in 2023, then rose by 11.27% to $509.5 million in 2024, then dropped by 11.1% to $452.9 million in 2025.
  • Its Total Current Liabilities was $452.9 million in Q3 2025, compared to $464.6 million in Q2 2025 and $486.7 million in Q1 2025.